| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Krystal Biotech, Inc. (KRYS) has 4 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. KRYS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.49M | $483.20M | - | |
| Pres | 1.43M | $462.26M | - | |
| Dir | 75.7K | $24.51M | - | |
| VP | 1.0K | $323.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 9, 2018 | Norby R Douglas | Director | Buy | 9,000 | $10.42 | $93,780.00 | New | |
| Mar 19, 2018 | Krishnan Krish S | President And CEO | Buy | 50,000 | $11.00 | $550,000.00 | +2.6% | |
| Sep 22, 2017 | Janney Daniel | Director | Buy | 200,000 | $10.00 | $2,000,000.00 | +153.2% | |
| Sep 22, 2017 | Krishnan Suma | Chief Operating Officer | Buy | 100,000 | $10.00 | $1,000,000.00 | +5.4% | |
| Sep 22, 2017 | Krishnan Krish S | President And CEO | Buy | 100,000 | $10.00 | $1,000,000.00 | +5.4% |